Literature DB >> 7099206

The phospholipases of Trypanosoma brucei bloodstream forms and cultured procyclics.

F R Opperdoes, J van Roy.   

Abstract

Phospholipase from Trypanosoma brucei bloodstream forms was characterized and subsequently localized. The enzyme had a specific activity of 100 nmol . min-1 . mg-1 protein. The major portion (greater than 90%) was a soluble phospholipase A1 with a pH optimum around 6; the remainder, also phospholipase A1, was particle-bound and had an optimal activity around pH 5.2. Both enzymes were maximally activated by 0.2% Triton X-100 but differed in their sensitivity towards the inhibitory action of higher concentrations of this detergent and diisopropyl fluorophosphate, the particle-bound activity being more sensitive than the soluble one. Cell fractionation showed that the particle-bound, more acidic phospholipase A1 was associated with alpha-mannosidase- and acid proteinase-containing lysosomes. Cultured procyclic trypomastigotes also contained phospholipase A but its specific activity was only 15% of that of bloodstream forms. This drastic reduction in overall activity upon transformation from bloodstream to culture form was the result of a decrease in soluble phospholipase, whereas the lysosomal activity essentially remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7099206     DOI: 10.1016/0166-6851(82)90038-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  15 in total

Review 1.  Bioactive lipids in Trypanosoma cruzi infection.

Authors:  Fabiana S Machado; Shankar Mukherjee; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

2.  Lysosomal phospholipase A1 in Trypanosoma cruzi: an enzyme with a possible role in the pathogenesis of Chagas' disease.

Authors:  M Wainszelbaum; E Isola; S Wilkowsky; J J Cannata; J Florin-Christensen; M Florin-Christensen
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  The role and characterization of phospholipase A1 in mediating lysophosphatidylcholine synthesis in Trypanosoma brucei.

Authors:  Gregory S Richmond; Terry K Smith
Journal:  Biochem J       Date:  2007-07-15       Impact factor: 3.857

4.  Lipid metabolism in Trypanosoma brucei: utilization of myristate and myristoyllysophosphatidylcholine for myristoylation of glycosyl phosphatidylinositols.

Authors:  K A Werbovetz; P T Englund
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

5.  A novel phospholipase from Trypanosoma brucei.

Authors:  Gregory S Richmond; Terry K Smith
Journal:  Mol Microbiol       Date:  2007-02       Impact factor: 3.501

6.  Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruzi.

Authors:  Shankar Mukherjee; Nikaeta Sadekar; Anthony W Ashton; Huan Huang; David C Spray; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2013-02-13       Impact factor: 2.289

7.  Free fatty acids released from phospholipids are the major heat-stable hemolytic factor of Entamoeba histolytica trophozoites.

Authors:  S Said-Fernández; R López-Revilla
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence.

Authors:  Mattie C Pawlowic; Kai Zhang
Journal:  Mol Biochem Parasitol       Date:  2012-08-28       Impact factor: 1.759

9.  Identification of Entamoeba histolytica intracellular phospholipase A and lysophospholipase L1 activities.

Authors:  J Vargas-Villarreal; H Martínez-Rodríguez; J Castro-Garza; B D Mata-Cárdenas; M T González-Garza; S Said-Fernández
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

10.  Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.

Authors:  Shankar Mukherjee; Fabiana S Machado; Huang Huang; Helieh S Oz; Linda A Jelicks; Cibele M Prado; Wade Koba; Eugene J Fine; Dazhi Zhao; Stephen M Factor; J Elias Collado; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.